Abstract
Genetically modified mice have been extensively used for analyzing the molecular events that occur during tumor development. In many, if not all, cases, however, it is uncertain to what extent the mouse models reproduce features observed in the corresponding human conditions1,2,3. This is due largely to lack of precise methods for direct and comprehensive comparison at the molecular level of the mouse and human tumors. Here we use global gene expression patterns of 68 hepatocellular carcinomas (HCCs) from seven different mouse models and 91 human HCCs from predefined subclasses4 to obtain direct comparison of the molecular features of mouse and human HCCs. Gene expression patterns in HCCs from Myc, E2f1 and Myc E2f1 transgenic mice were most similar to those of the better survival group of human HCCs, whereas the expression patterns in HCCs from Myc Tgfa transgenic mice and in diethylnitrosamine-induced mouse HCCs were most similar to those of the poorer survival group of human HCCs. Gene expression patterns in HCCs from Acox1−/− mice and in ciprofibrate-induced HCCs were least similar to those observed in human HCCs. We conclude that our approach can effectively identify appropriate mouse models to study human cancers.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hann, B. & Balmain, A. Building 'validated' mouse models of human cancer. Curr. Opin. Cell Biol. 13, 778–784 (2001).
Klausner, R.D. Studying cancer in the mouse. Oncogene 18, 5249–5252 (1999).
Rangarajan, A. & Weinberg, R.A. Opinion: Comparative biology of mouse versus human cells: modelling human cancer in mice. Nat. Rev. Cancer 3, 952–959 (2003).
Lee, J.S. et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 40, 667–676 (2004).
Kimura, M. Evolutionary rate at the molecular level. Nature 217, 624–626 (1968).
King, J.L. & Jukes, T.H. Non-Darwinian evolution. Science 164, 788–798 (1969).
Ureta-Vidal, A., Ettwiller, L. & Birney, E. Comparative genomics: genome-wide analysis in metazoan eukaryotes. Nat. Rev. Genet. 4, 251–262 (2003).
Cooper, G.M. & Sidow, A. Genomic regulatory regions: insights from comparative sequence analysis. Curr. Opin. Genet. Dev. 13, 604–610 (2003).
Eddy, S.R. Computational genomics of noncoding RNA genes. Cell 109, 137–140 (2002).
Hardison, R.C. Conserved noncoding sequences are reliable guides to regulatory elements. Trends Genet. 16, 369–372 (2000).
Rao, M.S., Lalwani, N.D., Watanabe, T.K. & Reddy, J.K. Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator. Cancer Res. 44, 1072–1076 (1984).
Reddy, J.K. & Lalwai, N.D. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. Crit. Rev. Toxicol. 12, 1–58 (1983).
Poirier, L.A. Hepatocarcinogenesis by diethylnitrosamine in rats fed high dietary levels of lipotropes. J. Natl. Cancer Inst. 54, 137–140 (1975).
Conner, E.A. et al. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis. Oncogene 19, 5054–5062 (2000).
Conner, E.A., Lemmer, E.R., Sanchez, A., Factor, V.M. & Thorgeirsson, S.S. E2F1 blocks and c-Myc accelerates hepatic ploidy in transgenic mouse models. Biochem. Biophys. Res. Commun. 302, 114–120 (2003).
Murakami, H. et al. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Cancer Res. 53, 1719–1723 (1993).
Fan, C.Y. et al. Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism. J. Biol. Chem. 273, 15639–15645 (1998).
Calvisi, D.F., Factor, V.M., Ladu, S., Conner, E.A. & Thorgeirsson, S.S. Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice. Gastroenterology 126, 1374–1386 (2004).
Bentley, P. et al. Hepatic peroxisome proliferation in rodents and its significance for humans. Food Chem. Toxicol. 31, 857–907 (1993).
Gonzalez, F.J., Peters, J.M. & Cattley, R.C. Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activator receptor alpha. J. Natl. Cancer Inst. 90, 1702–1709 (1998).
Rosenwald, A. et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 3, 185–197 (2003).
Shirahashi, H. et al. Ubiquitin is a possible new predictive marker for the recurrence of human hepatocellular carcinoma. Liver 22, 413–418 (2002).
Alizadeh, A.A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503–511 (2000).
Schaner, M.E. et al. Gene expression patterns in ovarian carcinomas. Mol. Biol. Cell 14, 4376–4386 (2003).
Sargent, L.M. et al. Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-Myc and transforming growth factor-alpha in the liver. Am. J. Pathol. 154, 1047–1055 (1999).
Laurent-Puig, P. et al. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology 120, 1763–1773 (2001).
Sambrook, J., Fritsch, E. & Maniatis, T. Molecular Cloning 7.19–7.22 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1989).
Meyer, K. et al. Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen. Carcinogenesis 24, 975–984 (2003).
Ellwood-Yen, K. et al. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 4, 223–238 (2003).
Tusher, V.G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA. 98, 5116–5121 (2001).
Acknowledgements
We thank R. Simon for discussions and advice on statistical analysis, J.W. Grisham for critical reading of the manuscript, E. Asaki for managing gene expression database and V.M. Factor and E.A. Conner for help with the mouse colonies.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Fig. 1
Correlation heat map. (PDF 101 kb)
Supplementary Fig. 2
Hierarchical clustering analysis of survival genes. (PDF 517 kb)
Supplementary Fig. 3
Comparison of predicted outcome. (PDF 38 kb)
Supplementary Fig. 4
Direct comparisons of top 500 orthologous genes. (PDF 43 kb)
Supplementary Fig. 5
Comparison of real-time RT-PCR and microarray experiments. (PDF 25 kb)
Supplementary Table 1
Complete list of 329 orthologous genes. (PDF 31 kb)
Supplementary Table 2
Comparison of mouse HCC and human DLBCL. (PDF 12 kb)
Supplementary Table 3
Comparison of mouse HCC and human ovarian cancer. (PDF 11 kb)
Rights and permissions
About this article
Cite this article
Lee, JS., Chu, IS., Mikaelyan, A. et al. Application of comparative functional genomics to identify best-fit mouse models to study human cancer. Nat Genet 36, 1306–1311 (2004). https://doi.org/10.1038/ng1481
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng1481
This article is cited by
-
Proteomic analysis of DEN and CCl4-induced hepatocellular carcinoma mouse model
Scientific Reports (2024)
-
Saroglitazar suppresses the hepatocellular carcinoma induced by intraperitoneal injection of diethylnitrosamine in C57BL/6 mice fed on choline deficient, l-amino acid- defined, high-fat diet
BMC Cancer (2023)
-
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
Nature Reviews Gastroenterology & Hepatology (2023)
-
ZNF498 promotes hepatocellular carcinogenesis by suppressing p53-mediated apoptosis and ferroptosis via the attenuation of p53 Ser46 phosphorylation
Journal of Experimental & Clinical Cancer Research (2022)
-
Folic acid depletion as well as oversupplementation helps in the progression of hepatocarcinogenesis in HepG2 cells
Scientific Reports (2022)